NCT04232267View on ClinicalTrials.gov

Analysis of Sleep Study Data to Assess Depressive Burden

CompletedOBSERVATIONAL
Enrollment

329

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Sleep DisorderDepressive; Behavioral DisorderMood Disorders
Interventions
DEVICE

MEB-001

Software medical device used to aid in the screening of patients with potential depressive burden symptoms.

Trial Locations (5)

43026

Ohio Sleep Solutions, Hilliard

43123

Ohio Sleep Solutions, Grove City

43214

Ohio Sleep Solutions, Columbus

55434

Restore Sleep Clinic, Blaine

55441

Lakeland Sleep and CPAP, Plymouth

All Listed Sponsors
lead

Medibio Limited

INDUSTRY

NCT04232267 - Analysis of Sleep Study Data to Assess Depressive Burden | Biotech Hunter | Biotech Hunter